Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

New method for preparing picoplatin

A technology of picoplatin and picoline, applied in the field of preparation of anti-tumor drug picoplatin, to achieve the effect of convenient industrial production

Active Publication Date: 2012-05-09
NANJING CHENGONG PHARM CO LTD
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0020] In summary, the shortcomings of the prior art for preparing picoplatin can be attributed to: since 2-picoline is a weakly basic substance, when it is combined with Potassium tetrachloroplatinate complex requires severe reaction conditions, which leads to a large loss of platinum in the preparation process, which inevitably brings complicated purification processes and expensive production costs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • New method for preparing picoplatin
  • New method for preparing picoplatin
  • New method for preparing picoplatin

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] This example illustrates the preparation of picoplatin.

[0052] In the reaction flask, add K under dark conditions 2 PtCl 4 (103.8g, 0.25mol), 1500mL of deionized water, and 500mL of an aqueous solution in which KI (166g, 1mol) was dissolved was added, and the mixture was stirred at 25°C for 2 hours. 2-Methylpyridine (23.3 g, 0.25 mol) was slowly added dropwise, and the mixture was stirred at 25°C for 8 hours. Filtrate and dry under reduced pressure to obtain potassium triiodo(2-picoline)platinate(II) potassium (170.0 g, 0.24 mol) in the form of brown crystalline powder, with a yield of 96%, and keep it sealed and protected from light for future use;

[0053] Potassium triiodo (2-picoline) platinum (II) (170.0 g, 0.24 mol), 25% ammonia (16.3 g, 0.24 mol), and 2000 mL of deionized water were stirred at room temperature and protected from light. Mix evenly, stir at 25°C for 8 hours, filter, wash the filter cake with pure water, and dry under vacuum at 45°C to obtain c...

Embodiment 2

[0056] The preparation method of the picoplatin of this embodiment is the same as that of Example 1, but the reaction conditions are changed.

[0057] In the reaction flask, add K under dark conditions 2 PtCl 4 (103.8g, 0.25mol), 1500mL of deionized water, and 500mL of an aqueous solution in which KI (166g, 1mol) was dissolved was added, and the mixture was stirred at 30°C for 2 hours. 2-Methylpyridine (23.3 g, 0.25 mol) was slowly added dropwise, and the mixture was stirred at 30° C. for 8 hours. Filtrate and dry under reduced pressure to obtain potassium triiodo(2-picoline)platinate(II) potassium (163.0 g, 0.23 mol) in the form of brown crystalline powder, with a yield of 92%, and store it in an airtight and dark place for future use;

[0058] Potassium triiodo (2-picoline) platinum (II) (163.0 g, 0.23 mol), 25% ammonia (15.6 g, 0.23 mol), and 2000 mL of deionized water were stirred at room temperature and protected from light. Mix well, stir at 30°C for 8 hours, filter, ...

Embodiment 3

[0061] The preparation method of the picoplatin of this embodiment is the same as that of Example 1, but the reaction conditions are changed.

[0062] In the reaction flask, add K under dark conditions 2 PtCl 4 (103.8g, 0.25mol), 1500mL of deionized water, and 500mL of an aqueous solution in which KI (166g, 1mol) was dissolved was added, and the mixture was stirred at 15°C for 1 hour. 2-Methylpyridine (23.3 g, 0.25 mol) was slowly added dropwise, and the mixture was stirred at 15° C. for 8 hours. Filter and dry under reduced pressure to obtain potassium triiodo(2-picoline)platinate(II) potassium (172.0 g, 0.24 mol) in the form of brown crystalline powder, with a yield of 97%, and store it in a sealed and dark place for future use;

[0063] Potassium triiodo (2-picoline) platinum (II) (172.0 g, 0.24 mol), 25% ammonia (16.3 g, 0.24 mol), and 2000 mL of deionized water were stirred at room temperature and protected from light. Mix evenly, stir at 15°C for 8 hours, filter, wash...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a novel method for preparing picoplatin. The technical scheme adopts following steps of: firstly generating potassium tetraiodoplatinate by reacting potassium tetrachloro platinum with potassium iodide to improve the activity of reactants; generating triiodo (2-picoline) platinum (II) potassium by reacting the potassium tetraiodoplatinate with 2- picoline; generating Cis-2 iodine-ammonia and (2-picoline) platinum (II) by reacting triiodo (2-picoline) platinum (II) potassium with ammonia water; adding the Cis-2 iodine-ammonia and the (2-picoline) platinum (II) togetherto deionized water; stirring the deionized water for reaction at the room temperature; filtering silver iodide precipitate when the reaction is completed; and adding potassium chloride so as to gradually separate out crystallized products of the picoplatin. In the invention, the reaction is more complete, the utilization of the platinum and the yield are enhanced, the products do not have silver irons, and the problem that the silver irons are exceeded needs not to be worried.

Description

technical field [0001] The invention relates to a preparation method of antitumor drug picoplatin, belonging to the technical field of pharmaceutical engineering. Background technique [0002] Picoplatin is a new generation of platinum anticancer drugs developed after cisplatin, carboplatin and oxaliplatin. Picoplatin is also known as: picoplatin, JM473, AMD473, ZD0473, etc., the English name is Picoplatin, the chemical name is cis-dichloro-ammonia, (2-picoline) platinum (II), molecular weight: 376.16, CAS : 181630-15-9, its chemical structure is as follows: [0003] [0004] Picoplatin was first researched and developed by Canadian AmorMed company. It is designed to reduce drug resistance through steric hindrance effect. Compared with cisplatin, picoplatin 2-picoline replaces one ammonia of cisplatin, and the methyl group is located on Pt. - Above the N plane, the steric hindrance of the reaction between the drug and other substances is increased, and the speed of its...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07F15/00
Inventor 郭昭
Owner NANJING CHENGONG PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com